Collection: Critical care

At helcima, we are committed to advancing critical care medicine through our innovative portfolio of therapies and solutions. With a deep understanding of the complexities of critical illness and a dedication to improving patient outcomes, we strive to provide comprehensive care for patients in the most acute and life-threatening situations.

Our Critical Care portfolio offers a comprehensive range of medications, devices, and technologies designed to support healthcare providers in managing critically ill patients across diverse clinical settings, including intensive care units (ICUs), emergency departments, and operating rooms. From advanced hemodynamic monitoring tools and mechanical ventilation devices to intravenous sedatives and analgesics, we are committed to optimizing patient care and safety in critical care environments.

Driven by our passion for innovation and guided by a commitment to excellence, we invest in research and development to bring forward-thinking solutions to the forefront of critical care medicine. From novel pharmacological agents to innovative resuscitation strategies and tele-ICU technologies, we are dedicated to improving outcomes, reducing complications, and enhancing the delivery of critical care services.

helcima's Critical Care portfolio reflects our unwavering dedication to quality, safety, and patient-centered care. By collaborating with leading critical care specialists, emergency medicine physicians, and trauma teams, we aim to develop evidence-based practices and technologies that optimize patient care delivery and promote positive outcomes for critically ill patients.